Candel appoints Diem Nguyen to board; adopts amended charter and bylaws upon IPO

Candel Therapeutics, Inc.

Diem Nguyen appointed to newly created board vacancy, effective July 26, 2021, as Class III director.
Nguyen is independent and will receive standard non-employee director compensation.
Restated certificate authorizes 150M shares of common stock and 10M shares of undesignated preferred.
Amended bylaws eliminate stockholder action by written consent and set procedures for proposals and nominations.

item 5.02 item 5.03 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Diem Nguyen

Director

CADL · Candel Therapeutics, Inc.

Effective: 2021-07-26
Filed: July 30, 2021, 7:59 PM ET

On July 12, 2021, the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) unanimously appointed Diem Nguyen, Ph.D. to fill a newly created vacancy on the Board

Departed

Carrie Cox

Director

CADL · Candel Therapeutics, Inc.

Effective: 2021-07-26
Successor: Diem Nguyen
Filed: July 30, 2021, 7:59 PM ET

resulting from the resignation of Carrie Cox from the Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Diem Nguyen was appointed as Director at Candel Therapeutics, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 12, 2021, the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) unanimously appointed Diem Nguyen, Ph.D. to fill a newly created vacancy on the Board

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Carrie Cox resigned as Director at Candel Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

resulting from the resignation of Carrie Cox from the Board

View on SEC.gov

Candel Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-21-229437

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.